Artificial Intelligence Alloy Therapeutics | Drug Discovery Platforms


Enterprise, Biotechnology, Biopharma, Health Care, Life Science, Drug Discovery, Medicine Lexington, MA, United States

Alloy Therapeutics

Artificial Intelligence


Alloy Therapeutics | Drug Discovery Platforms

Alloy Therapeutics

Biotechnology, Biopharma, Health Care, Life Science, Drug Discovery, Medicine


Lexington, MA, United States

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. We provide affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. Our lead offering, the ATX-Gx™ platform, is a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains.

Founded in 2017 and privately funded by visionary investors, we are headquartered in Boston, MA with European labs in Cambridge, UK. As a reflection of our relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation.

 

B2B

101 to 250

Series C

$75 M

Scaling Up

2017

 
 

Healthcare
Biotechnology

N/A

N/A

 
 

Service

Yes

Active

 
 

N/A


Drug Discovery

Drug Discovery

Biotechnology

Biotechnology


N/A

 

   Software


N/A


N/A

 
 

View All

Technology Specialist, Nanoparticles

Lexington, Massachusetts

Technology Specialist, mRNA & ASO

Lexington, Massachusetts

Senior Scientist, Phage Display

Lexington, Massachusetts

Scientist, T Cell Biology

Lexington, Massachusetts

Scientist, Genetically Engineered Organisms

Lexington, Massachusetts

 

AI/ML Professionals

Want to work at Alloy Therapeutics?

We can introduce you to the right person at Alloy Therapeutics

Talk to our Talent Team

 

5

1

$75M

Company was founded 2017 and it took almost 4 years (Apr 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/02/2021

Series C

$75M

Presight Capital, Mubadala Capital Ventures, Gaingels, Founders Fund, 8VC

Date : 04/02/2021

Round: Series C

$ Raised: $75M

Investors: Presight Capital, Mubadala Capital Ventures, Gaingels, Founders Fund, 8VC

 

Investors

Interested in researching Alloy Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Alloy Therapeutics

Request a Demo - Deal Souring Platform

 
Errik Anderson


Errik Anderson
CEO, Chairman, Founder

Jay Rosanelli


Jay Rosanelli
Chief Operating Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Alloy Therapeutics